Cogentus Pharma Raises $62.5 Million

Cogentus Pharmaceuticals Inc., a Menlo Park, Calif.-based company, has completed a $62.5 million private placement that will allow it to advance its novel antiplatelet therapy for cardiovascular disease. Keffi Group of New York led the Series C financing, with participation from Apothecary Capital of Chicago; Pinnacle Ventures and Prospect Venture Partners, both of Palo Alto, Calif.; and Ridgeback Capital of New York.